filmov
tv
Novartis CEO discusses developing a new Covid-19 treatment
Показать описание
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
#CNBC
#CNBCTV
Novartis CEO discusses how AI will impact drug development
Novartis CEO discusses developing a new Covid-19 treatment
Novartis CEO Vas Narasimhan on The David Rubenstein Show
Novartis CEO: Our leukemia drug Scemblix is a potential $3 billion plus medicine
Novartis CEO Discusses Impact of Trump on Drug Industry
Novartis CEO on Acquisitions, AI, Weight-Loss Drugs
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Novartis CEO: Company set to become a pure play, innovative medicine business after Sandoz spin off
Novartis CEO Vas Narasimhan: Expect solid growth this year top and bottom line
Reimagining Medicine with Data & Digital | Novartis CEO at #VivaTech19
AI, vaccine distrust, & the future of healthcare: Novartis CEO
Novartis CEO on new cancer therapy programs
Innovative medicines business returning to growth, Novartis CEO says
'We have reached an endemic environment with Covid,' says Novartis CEO
Novartis CEO Narasimhan on Growth Prospects, Pandemic Disruption
Vas Narasimhan and Sarah Kate Ellis discuss inclusivity.
Focus remains on R&D to drive growth of blockbuster drugs, says Novartis CEO
Novartis CEO: Expect continued growth in 2023
A message about Managed Access from Vas Narasimhan CEO Novartis
Novartis CEO: Spinoffs will see us succeed as a pure-play innovative medicines company
Novartis CEO on ESG: Pandemic has been a reset for pharma's reputation
Novartis Can Meet Growing Demand for Gene Therapy: CEO
Novartis starts strategic review of Sandoz generic drug unit: CEO
Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug
Комментарии